/PLSH
PLSH Stock - Panacea Life Sciences Holdings, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.09+0.00%
+$0.00 (+0.00%) • Dec 19
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PLSH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.09 – $0.10
TARGET (TP)$0.11
STOP LOSS$0.09
RISK/REWARD1:3.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta3.28
52W High$0.20
52W Low$0.03
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $4.11M | $2.38M | $1.63M | $2.06M | $9.02M |
| Gross Profit | $2.85M | $-4,089,742 | $396,470 | $540,578 | $2.00M |
| Gross Margin | 69.4% | -171.5% | 24.4% | 26.2% | 22.2% |
| Operating Income | $-2,575,709 | $-5,546,154 | $-5,398,451 | $-5,540,489 | $-5,257,842 |
| Net Income | $-583,200 | $-8,015,300 | $-11,098,327 | $-6,124,202 | $-6,994,996 |
| Net Margin | -14.2% | -336.1% | -682.1% | -297.3% | -77.6% |
| EPS | $-0.03 | $-0.48 | $-0.75 | $-0.34 | $-0.41 |
Company Overview
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. It is also involved in the personal protection equipment (PPE) business, including importing and selling PPE hand sanitizers and masks, as well as white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PLSHBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2025
EPS Surprise History
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q4 24
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 12, 2026 | — | — | — | — |
Q4 2025 | Nov 12, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 4, 2025 | — | $0.09 | — | — |
Q2 2025 | May 14, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 31, 2024 | — | $0.17 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-0.06 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.07 | — | — |
Q2 2024 | May 6, 2024 | — | $-0.09 | — | — |
Q2 2024 | Apr 1, 2024 | — | $-0.13 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.13 | — | — |
Q3 2023 | Aug 15, 2023 | — | $-0.11 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.12 | — | — |
Q1 2023 | Mar 30, 2023 | — | $-0.12 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.18 | — | — |
Q3 2022 | Aug 15, 2022 | — | $-0.13 | — | — |
Q2 2022 | May 13, 2022 | — | $-0.19 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.14 | — | — |
Q4 2021 | Dec 20, 2021 | — | $-0.14 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.15 | — | — |
Q2 2021 | May 27, 2021 | — | $0.02 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PLSH
What is PLSH's current stock price?
Panacea Life Sciences Holdings, Inc. (PLSH) is currently trading at $0.09 per share. The stock has moved +0.00% today.
What is the analyst price target for PLSH?
No analyst price targets are currently available for this stock.
What sector is Panacea Life Sciences Holdings, Inc. in?
Panacea Life Sciences Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is PLSH's market cap?
Panacea Life Sciences Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does PLSH pay dividends?
No, Panacea Life Sciences Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALID
Allied Corp.
$0.00
Mkt Cap: $0.0B
ANTCF
Aion Therapeutic Inc.
$0.00
Mkt Cap: $0.0B
BHNGF
Bhang Inc.
$0.00
Mkt Cap: $0.0B
CBDY
Target Group Inc.
$0.00
Mkt Cap: $0.0B
CNNA
Cann American Corp.
$0.00
Mkt Cap: $0.0B
EXMT
Anything Technologies Media, Inc.
$0.00
Mkt Cap: $0.0B
JWCAF
James E. Wagner Cultivation Corporation
$0.00
Mkt Cap: $0.0B
KOAN
Resonate Blends, Inc.
$0.00
Mkt Cap: $0.0B
MJARF
MJardin Group, Inc.
$0.00
Mkt Cap: $0.0B
OWPC
One World Products, Inc.
$0.03
Mkt Cap: $0.0B
Explore stocks similar to PLSH for comparison